25 - 27 September, 2017 | Sheraton Philadelphia University City Hotel, Philadelphia, PA

Meet the Advisory Board and Speakers

Advisory Board


Ramana Sonty
Ramana Sonty
Director, Global Medical Organization
Johnson & Johnson
Anne B. Cropp
Anne B. Cropp
Chief Scientific Officer
Early Access Care, LLC
Naomi Lopez Bauman
Naomi Lopez Bauman
Director of Healthcare Policy
Goldwater Institute
Brian J. Malkin
Brian J. Malkin
FDA Counsel
Arent Fox LLP
Beth E. Roxland
Beth E. Roxland
Senior Consultant on Law, Policy, and Ethics; Associate Division of Medical Ethics
NYU Langone School of Medicine
Jennifer  McNary
Jennifer McNary
Patient Advocate
Beauhawks Foundation
Andrew McFadyen
Andrew McFadyen
Executive Director
The Isaac Foundation
Frank Burroughs
Frank Burroughs
CEO
Abigail Alliance for Better Access to Developmental Drugs
Tom Watson
Tom Watson
Pre-approval Access Consultant
TW Consulting Group
Mark Corbett
Mark Corbett
Executive Vice President
Inceptua Medicines Access
Sjaak Vink
Sjaak Vink
CEO
The Social Medwork
Kevin J. Weatherwax
Kevin J. Weatherwax
Administrative Program Director; Co-Chair - Expanded Access Oversight Committee
University of Michigan Health System
Ana Lita
Ana Lita
Co-Founder and Executive Director
Global Bioethics Initiative Inc.
John Lagus
John Lagus
Head of Managed Access
Clinigen Group

Speakers


Ramana Sonty
Ramana Sonty
Director, Global Medical Organization
Johnson & Johnson
Pat Furlong
Pat Furlong
President & CEO
Parent Project Muscular Dystrophy
Anne B. Cropp
Anne B. Cropp
Chief Scientific Officer
Early Access Care
Beverly  Harrison
Beverly Harrison
Head, Patient Support
Johnson and Johnson
Christine  MacCracken
Christine MacCracken
Director, Patient Support
Janssen Pharmaceutical Companies of Johnson & Johnson
Paul Aliu
Paul Aliu
Global Head Medical Governance, Chief Medical Office
Novartis
Richard Klein
Richard Klein
Former Director, FDA Patient Liaison Program at Food and Drug Administration
FDA
Jessica Imrie
Jessica Imrie
Rare Diseases, Gene Therapy Head of Strategy and Operations
GSK
Karen Bartels
Karen Bartels
Director, Global Medical Affairs, Early Clinical Development and External Research
AstraZeneca
Luiz Andre Magno
Luiz Andre Magno
Global Medical Affairs Leader - Neuroscience
Janssen Pharmaceutical
Arun Kumar
Arun Kumar
President & CEO
Neuracon Biotech Inc
Romina Oxborough
Romina Oxborough
Director Clinigen Consulting
Clinigen Group
Alison Bateman-House
Alison Bateman-House
Assistant Professor – Division of Medical Ethics
NYU
June Wasser
June Wasser
Executive Director and CEO
Reagan-Udall Foundation for the FDA
Naomi  Lopez Bauman
Naomi Lopez Bauman
Director of Healthcare Policy
Goldwater Institute
Catherine Blansfield
Catherine Blansfield
Vice President of Patient Services
National Organization for Rare Disorders (NORD)
Paul Melmeyer
Paul Melmeyer
Director of Federal Policy
National Organization for Rare Disorders (NORD)
Brian Malkin
Brian Malkin
FDA Counsel
Arent Fox LLP
Tom Watson
Tom Watson
Pre-approval Access Consultant
TW Consulting Group
Jane  Reese-Coulbourne
Jane Reese-Coulbourne
Senior Consultant
MK&A
Andrew  McFadyen
Andrew McFadyen
Executive Director
The Isaac Foundation
Frank Burroughs
Frank Burroughs
Founder & CEO
Abigail Alliance for Better Access to Developmental Drugs
Jennifer McNary
Jennifer McNary
Patient Advocate
Beauhawks Foundation
Kevin J.  Weatherwax
Kevin J. Weatherwax
Administrative Program Director; Co-Chair - Expanded Access Oversight Committee
University of Michigan Health System